Company intelligence / Profile preview

BMG Pharma

Ownership: Private
Development stage: Commercial

Overview

BMG Pharma has an extensive portfolio with many marketed products based on its patented Hyaluromimethic® Technology. The company focuses on innovative solutions in the fields of oral care, dermatology/aesthetic medicine, osteoarthritis and supportive care. It operates internationally through partnerships in over 60 countries. Clinical results are not detailed but the company emphasizes commercialized products and ongoing development.

Therapeutic areas: OtherDermatologyRheumatologyMen's Health
Modalities: biomaterialsmacromoleculespolysaccharides (notably hyaluronic acid derivatives)medical devices
Industry: Therapeutic Medical Devices

Partnerships

International commercialization partners marketing its products across Europe, Middle East, Asia & Latin America (>60 countries)

Beyond the preview

Go deeper on BMG Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BMG Pharma.